Cadrenal Therapeutics (CVKD) Assets Average (2023 - 2026)
Cadrenal Therapeutics (CVKD) posted Assets Average of $3.6 million for Q1 2026, down 14.57% sequentially from $4.2 million in Q4 2025, and down 60.23% YoY from $9.0 million in Q1 2025.
Cadrenal Therapeutics (CVKD) Assets Average (2023 - 2026) Analysis & Trends
Cadrenal Therapeutics has reported Assets Average for 4 years, with the latest figure at $3.6 million in Q1 2026.
- Quarterly Assets Average fell 60.23% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (down 60.23% YoY) and the FY2025 annual result came in at $7.2 million, down 22.49% from the prior year.
- Assets Average slipped to $3.6 million in Q1 2026 per CVKD's latest filing, from $4.2 million in the prior quarter.
- Over five years, Assets Average peaked at $9.0 million in Q1 2025 and troughed at $2.6 million in Q1 2023.
- A 4-year average of $5.9 million and a median of $6.3 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2024 and 2026: Assets Average soared 195.95% in 2024, then sank 60.23% in 2026.
- Over 4 years, Assets Average stood at $8.9 million in 2023, then fell by 16.98% to $7.4 million in 2024, then plunged by 43.16% to $4.2 million in 2025, then slipped by 14.57% to $3.6 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $3.6 million, $4.2 million, and $5.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Cadrenal Therapeutics | 4.59 Mn | 2.19 Mn | - | 4.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.23 Mn |
| Mar 31, 2026 | 3.59 Mn |
| Dec 31, 2025 | 4.21 Mn |
| Sep 30, 2025 | 5.03 Mn |
| Jun 30, 2025 | 6.97 Mn |
| Mar 31, 2025 | 9.04 Mn |
| Dec 31, 2024 | 7.40 Mn |
| Sep 30, 2024 | 5.07 Mn |
| Jun 30, 2024 | 6.25 Mn |
| Mar 31, 2024 | 7.78 Mn |
| Dec 31, 2023 | 8.92 Mn |
| Sep 30, 2023 | 6.44 Mn |
| Jun 30, 2023 | 4.02 Mn |
| Mar 31, 2023 | 2.63 Mn |